{"id":"W4410080762","doi":"10.1016/s1470-2045(25)00140-8","title":"Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study","year":2025,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Ottawa Hospital; Jewish General Hospital","funders":"Jazz Pharmaceuticals; Pfizer","keywords":"Fulvestrant; Palbociclib; Metastatic breast cancer; Medicine; Oncology; Internal medicine; Cancer; Breast cancer; Hormone receptor; Gynecology; Estrogen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004037845,0.0004488604,0.001417111,0.0001437673,0.0001425322,0.00003363887,0.000252929,0.00009254141,0.00004140918],"category_scores_gemma":[0.00007196821,0.0003008114,0.00005205585,0.0005338352,0.0004062729,0.0001997422,0.0001326484,0.0005357658,0.000006001344],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001246117,"about_ca_system_score_gemma":0.0004347434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004085582,"about_ca_topic_score_gemma":0.003433229,"domain_scores_codex":[0.9967597,0.0007803221,0.000671251,0.000800102,0.0003123536,0.0006762688],"domain_scores_gemma":[0.9977697,0.000839629,0.0003878887,0.0006191241,0.0002295697,0.0001541098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4380078,0.02449208,0.1194335,0.0002043408,0.004461414,0.0008529251,0.03194963,0.0003027972,0.007354428,0.00004714668,0.000811222,0.3720827],"study_design_scores_gemma":[0.2681205,0.01081736,0.7109787,0.001163518,0.001772535,0.00006083242,0.003061636,0.000240172,0.0005997138,0.00008482615,0.002577842,0.0005223796],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863147,0.002129946,0.00007203074,0.004016004,0.0001391538,0.003707949,0.00299005,0.00009975814,0.0005304826],"genre_scores_gemma":[0.9951106,0.0005557733,0.001227613,0.001467396,0.000215105,0.0003110392,0.0009075802,0.00005064191,0.0001542532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5915452,"threshold_uncertainty_score":0.9999444,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02242860463022142,"score_gpt":0.3244790213498309,"score_spread":0.3020504167196095,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}